Evolving profile of the use and clinical outcomes of transcatheter aortic valve implantation (TAVI) and surgical aortic valve implantation (SAVR) in Québec: A real-world evaluation from 2013 to 2019

Sondage - Qu’avez-vous pensé du l’état des pratiques : TAVI-RVA

The present document provides a portrait of use, patient management, and clinical outcomes of transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR), with or without coronary artery bypass grafting (CABG), in the ‘real-world’ setting of care in Québec from 2013 to 2019. Among other findings, an increase in the number of TAVI treatments in Québec between 2013 and 2019 is noted, which is accompanied by an overall improvement in short-term survival for patients treated for severe and symptomatic aortic stenosis. The increasing use of TAVI does not currently affect rates of SAVR in the province.